{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:18:22Z","timestamp":1787735902740,"version":"build-2784847793"},"reference-count":35,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Objective: Anti-M\u00fcllerian hormone (AMH) is the most widely used biochemical marker of ovarian reserve, but its associations with other reproductive hormones are usually examined one hormone at a time and without accounting for values reported at the assay floor. This study examined the associations between serum AMH and age, follicle-stimulating hormone (FSH), luteinising hormone (LH), estradiol, progesterone and prolactin in women attending a tertiary gynaecology clinic. Materials and Methods: In this retrospective, cross-sectional, single-centre study, the records of women who underwent serum AMH testing together with a reproductive hormone panel between 1 January 2020 and 31 December 2025 were reviewed. Women with polycystic ovary syndrome, primary ovarian insufficiency, pregnancy or previous ovarian surgery were excluded. Bivariate associations were assessed with Pearson and Spearman correlation coefficients on raw and Box\u2013Cox-transformed variables. Because 12.82% (n = 15) of AMH results were left-censored at the analytical reporting floor of 0.02 ng\/mL, a multivariable Tobit model with the censoring limit specified on the Box\u2013Cox-transformed scale (\u03bb = 0.309, threshold = \u22122.270) was fitted, with predictors selected a priori on clinical grounds. Sensitivity analyses examined the influence of high AMH values, an alternative transformation of AMH, and flexible modelling of age. Results: The analysis included 117 women aged 18\u201345 years. Mean AMH was 2.22 \u00b1 2.24 ng\/mL [median 1.61 ng\/mL (Q1\u2013Q3, 0.36\u20133.20)]. In bivariate correlation analysis, AMH showed statistically significant inverse associations with age (r = \u22120.376, p &lt; 0.001) and FSH (r = \u22120.445, p &lt; 0.001), whereas LH, estradiol, progesterone, and prolactin showed no statistically significant correlations with AMH (all p &gt; 0.10). In the multivariable Tobit model, only age (\u03b2 = \u22120.068; 95% CI [\u22120.117, \u22120.018]; p = 0.007) and transformed FSH (\u03b2 = \u22123.582; 95% CI [\u22124.846, \u22122.317]; p &lt; 0.001) remained independently associated with transformed AMH. LH, estradiol, progesterone, and prolactin were not independently associated with AMH in the multivariable model (all p &gt; 0.05). The standardised association was greater for transformed FSH (\u03b2* = \u22120.559) than for age (\u03b2* = \u22120.234). The associations of age and FSH were consistent in direction and magnitude across all sensitivity analyses. Conclusions: In this selected clinical sample, age and FSH were the only variables independently associated with serum AMH after mutual adjustment. LH, estradiol, progesterone, and prolactin showed no statistically significant associations with AMH in either the unadjusted bivariate analyses or the multivariable model. The absence of independent associations for these hormones should be interpreted cautiously because hormone sampling was not standardised to menstrual cycle day, which may have introduced measurement variability. These findings describe associations within the study population and do not establish causal relationships, reference intervals, or a basis for modifying testing strategies. The analysis also highlights the importance of accounting for left-censoring when modelling AMH data containing a substantial proportion of results at the assay reporting floor.<\/jats:p>","DOI":"10.3390\/metabo16090610","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:11:15Z","timestamp":1787731875000},"page":"610","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age and Follicle-Stimulating Hormone as Variables Independently Associated with Serum Anti-M\u00fcllerian Hormone in Women Attending a Tertiary Gynaecology Clinic: A Retrospective Cross-Sectional Study Using Censoring-Aware Modelling"],"prefix":"10.3390","volume":"16","author":[{"given":"Mete Hakan","family":"Karal\u00f6k","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34403, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-5911","authenticated-orcid":false,"given":"Ba\u011fnu","family":"D\u00fcndar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34403, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Parmaks\u0131z","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, Istanbul Health and Technology University, Istanbul 34445, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-6892","authenticated-orcid":false,"given":"Tugba","family":"Elg\u00fcn","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Biruni University, Istanbul 34015, T\u00fcrkiye"},{"name":"Biruni University Research Center (B@MER), Biruni University, Istanbul 34015, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi Ko\u00e7yi\u011fit","family":"Sevin\u00e7","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Medicine, Kutahya Health Sciences University, K\u00fctahya 43100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6424-7411","authenticated-orcid":false,"given":"Asiye G\u00f6k","family":"Yurtta\u015f","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34403, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-M\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: Update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: From theory to practice","volume":"20","author":"Sunkara","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","article-title":"Evaluation of female fertility\u2014AMH and ovarian reserve testing","volume":"107","author":"Cedars","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: Ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-M\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: The role of anti-M\u00fcllerian hormone","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/jc.2012-1829","article-title":"Ovarian antral follicle subclasses and anti-M\u00fcllerian hormone during normal reproductive aging","volume":"98","author":"Bentzen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/GCO.0000000000000175","article-title":"Ovarian response biomarkers: Physiology and performance","volume":"27","author":"Iliodromiti","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.rbmo.2009.11.010","article-title":"Anti-M\u00fcllerian hormone follow-up in young women treated by chemotherapy for lymphoma: Preliminary results","volume":"20","author":"Decanter","year":"2010","journal-title":"Reprod. BioMed. Online"},{"key":"ref_12","unstructured":"Practice Committee of the American Society for Reproductive Medicine, and Practice Committee of the American Society for Reproductive Medicine (2020). Testing and interpreting measures of ovarian reserve: A committee opinion. Fertil. Steril., 114, 1151\u20131157."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/humupd\/dmac045","article-title":"Anti-M\u00fcllerian hormone for the diagnosis and prediction of menopause: A systematic review","volume":"29","author":"Nelson","year":"2023","journal-title":"Hum. Reprod. Update"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ecl.2015.05.010","article-title":"Endocrinology of the menopause","volume":"44","author":"Hall","year":"2015","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.rbmo.2014.02.003","article-title":"Novel aspects of the endocrinology of the menstrual cycle","volume":"28","author":"Messinis","year":"2014","journal-title":"Reprod. BioMed. Online"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1172\/JCI64455","article-title":"Hyperprolactinemia and infertility: New insights","volume":"122","author":"Kaiser","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.fertnstert.2009.07.1674","article-title":"Anti-M\u00fcllerian hormone and inhibin B variability during normal menstrual cycles","volume":"94","author":"Sowers","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhai, Y., Li, L., Lu, Y., Su, S., Liu, Y., Xu, Z., Xin, M., Zhang, Q., and Cao, Z. (2022). Divergent associations between serum androgens and ovarian reserve markers revealed in patients with polycystic ovary syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.881740"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-M\u00fcllerian hormone in a large population-based study","volume":"98","author":"Verschuren","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/1907382","article-title":"Estimation of relationships for limited dependent variables","volume":"26","author":"Tobin","year":"1958","journal-title":"Econometrica"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Helsel, D.R. (2012). Statistics for Censored Environmental Data Using Minitab and R, John Wiley & Sons. [2nd ed.].","DOI":"10.1002\/9781118162729"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.fertnstert.2015.12.023","article-title":"Comparative assessment of five serum antim\u00fcllerian hormone assays for the diagnosis of polycystic ovary syndrome","volume":"105","author":"Pigny","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Punchoo, R., and Bhoora, S. (2021). Variation in the Measurement of Anti-M\u00fcllerian Hormone\u2014What Are the Laboratory Issues?. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.719029"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations","volume":"26","author":"Box","year":"1964","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Harrell, F.E. (2015). Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis, Springer. [2nd ed.].","DOI":"10.1007\/978-3-319-19425-7"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.fertnstert.2013.10.021","article-title":"Reference range for the antim\u00fcllerian hormone Generation II assay: A population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram","volume":"101","author":"Nelson","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Aslan, K., Kasapoglu, I., Kosan, B., Tunali, A., Tellioglu, I., and Uncu, G. (2025). Age-stratified anti-M\u00fcllerian hormone (AMH) nomogram: A comprehensive cohort study including 22.920 women. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1612194"},{"key":"ref_32","unstructured":"Feingold, K.R., Adler, R.A., Ahmed, S.F., Anawalt, B., Blackman, M.R., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2025). Ovarian Reserve Testing. Endotext, MDText.com, Inc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age","volume":"318","author":"Steiner","year":"2017","journal-title":"JAMA"},{"key":"ref_34","unstructured":"Clinical and Laboratory Standards Institute (2010). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline, CLSI. [3rd ed.]. CLSI document EP28-A3c."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum. Reprod."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/9\/610\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:30:13Z","timestamp":1787733013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/9\/610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["metabo16090610"],"URL":"https:\/\/doi.org\/10.3390\/metabo16090610","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}